Literature DB >> 28154089

Genetic polymorphism at BCL2 as a predictor for rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone efficacy in patients with diffuse large B-cell lymphoma.

Morteza Bashash1,2, Joseph M Connors3,4, Randy D Gascoyne5,4, Barbara Meissner4, Johanna M Schuetz6, Stephen Leach1, Graham W Slack5,4, Brian R Berry7, Howard Hu2, Laurie H Sehn3,4, Angela R Brooks-Wilson6,7,8, John J Spinelli9,10.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28154089      PMCID： PMC5477624          DOI： 10.3324/haematol.2016.159087

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  14 in total

1.  BCL2 predicts survival in germinal center B-cell-like diffuse large B-cell lymphoma treated with CHOP-like therapy and rituximab.

Authors:  Javeed Iqbal; Paul N Meyer; Lynette M Smith; Nathalie A Johnson; Julie M Vose; Timothy C Greiner; Joseph M Connors; Louis M Staudt; Lisa Rimsza; Elaine Jaffe; Andreas Rosenwald; German Ott; Jan Delabie; Elias Campo; Rita M Braziel; James R Cook; Raymond R Tubbs; Randy D Gascoyne; James O Armitage; Dennis D Weisenburger; Wing C Chan
Journal:  Clin Cancer Res       Date:  2011-09-20       Impact factor: 12.531

2.  BCL2 genotypes: functional and neurobehavioral outcomes after severe traumatic brain injury.

Authors:  Nicole Zangrilli Hoh; Amy K Wagner; Sheila A Alexander; Robert B Clark; Sue R Beers; David O Okonkwo; Dianxu Ren; Yvette P Conley
Journal:  J Neurotrauma       Date:  2010-08       Impact factor: 5.269

3.  Ongoing improvement in outcomes for patients diagnosed as having Non-Hodgkin lymphoma from the 1990s to the early 21st century.

Authors:  Dianne Pulte; Adam Gondos; Hermann Brenner
Journal:  Arch Intern Med       Date:  2008-03-10

4.  Genome-Wide Association Study of Event-Free Survival in Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy.

Authors:  Hervé Ghesquieres; Susan L Slager; Fabrice Jardin; Amelie S Veron; Yan W Asmann; Matthew J Maurer; Thierry Fest; Thomas M Habermann; Marie C Bene; Anne J Novak; Sylvain Mareschal; Corinne Haioun; Thierry Lamy; Stephen M Ansell; Herve Tilly; Thomas E Witzig; George J Weiner; Andrew L Feldman; Ahmet Dogan; Julie M Cunningham; Curtis L Olswold; Thierry Jo Molina; Brian K Link; Noel Milpied; David G Cox; Gilles A Salles; James R Cerhan
Journal:  J Clin Oncol       Date:  2015-10-12       Impact factor: 44.544

5.  Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia.

Authors:  Laurie H Sehn; Jane Donaldson; Mukesh Chhanabhai; Catherine Fitzgerald; Karamjit Gill; Richard Klasa; Nicol MacPherson; Susan O'Reilly; John J Spinelli; Judy Sutherland; Kenneth S Wilson; Randy D Gascoyne; Joseph M Connors
Journal:  J Clin Oncol       Date:  2005-06-13       Impact factor: 44.544

Review 6.  Genome-wide association studies in diverse populations.

Authors:  Noah A Rosenberg; Lucy Huang; Ethan M Jewett; Zachary A Szpiech; Ivana Jankovic; Michael Boehnke
Journal:  Nat Rev Genet       Date:  2010-05       Impact factor: 53.242

7.  Toxicity and response criteria of the Eastern Cooperative Oncology Group.

Authors:  M M Oken; R H Creech; D C Tormey; J Horton; T E Davis; E T McFadden; P P Carbone
Journal:  Am J Clin Oncol       Date:  1982-12       Impact factor: 2.339

8.  Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells.

Authors:  D L Vaux; S Cory; J M Adams
Journal:  Nature       Date:  1988-09-29       Impact factor: 49.962

9.  Comprehensive pathway-based analysis identifies associations of BCL2, GNAO1 and CHD2 with non-obstructive azoospermia risk.

Authors:  Yufeng Qin; Juan Ji; Guizhen Du; Wei Wu; Juncheng Dai; Zhibin Hu; Jiahao Sha; Bo Hang; Chuncheng Lu; Yankai Xia; Xinru Wang
Journal:  Hum Reprod       Date:  2014-02-18       Impact factor: 6.918

10.  Candidate gene association study in pediatric acute lymphoblastic leukemia evaluated by Bayesian network based Bayesian multilevel analysis of relevance.

Authors:  Orsolya Lautner-Csorba; András Gézsi; Agnes F Semsei; Péter Antal; Dániel J Erdélyi; Géza Schermann; Nóra Kutszegi; Katalin Csordás; Márta Hegyi; Gábor Kovács; András Falus; Csaba Szalai
Journal:  BMC Med Genomics       Date:  2012-09-28       Impact factor: 3.063
View more
  1 in total

Review 1.  Diffuse Large B-Cell Lymphoma's New Genomics: The Bridge and the Chasm.

Authors:  Jennifer L Crombie; Philippe Armand
Journal:  J Clin Oncol       Date:  2020-08-19       Impact factor: 44.544
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.